Mesa Laboratories, Inc.
NASDAQ:MLABHardware, Equipment & Parts
-$0.15 today
- Market cap
- $774.56M
- Beta
- 0.93
- P/E (TTM)
- 78.3
- EPS (TTM)
- $1.21
- Dividend yield
- 0.68%
Volume 0.07M
Average 0.16M
MLAB Total Debt
Short-term and long-term borrowings combined.
Mesa Laboratories, Inc.NASDAQ: MLAB
Total Debt · Q4 FY2026 · quarter ended Mar 2026
Total debt falls 7.0% from a year ago
Total debt stood at $168.83M at the end of Q4 FY2026, down 7.0% from a year earlier and up 63.3% from the prior quarter. Over 3 fiscal years it compounded at -3.2% a year.
Context
- Total debt amounted to 39.5% of total assets at the end of Q4 FY2026, down 2.4 pp from a year earlier.
- Total debt increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -7.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2026
- 168.83M USD
- Year-over-year change
- -7.0%
- 4-year CAGR
- -6.5%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 168.83M | -7.0% |
| FY2025 | 2025-03-31 | 181.47M | -21.5% |
| FY2024 | 2024-03-31 | 231.3M | +24.3% |
| FY2023 | 2023-03-31 | 186.14M | -15.8% |
| FY2022 | 2022-03-31 | 221.13M | — |
Total Debt vs competitors
How MLAB compares with its peers on the latest reported figures
- MLAB's Mar 2026 total debt of $168.83M is the 9th highest of the 11 companies compared; the peer median is $953.54M.
- Its year-over-year change of -7.0% is the 7th highest of 11, against a peer median of -3.7%.
- Total debt amounts to 39.5% of total assets for MLAB, versus a peer median of 27.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $41.37B | +15.9% | +3.0% | 36.2% | |
| Jul 2026 | $3.95B | +15.8% | +6.6% | 28.3% | |
| Jul 2026 | $3.34B | -1.0% | -8.5% | 27.7% | |
| Jun 2026 | $1.64B | +13.8% | -6.5% | 27.9% | |
| Jun 2026 | $1.2B | -14.4% | +3.3% | 11.7% | |
| Mar 2026 | $703.39M | +0.6% | -7.1% | 89.9% | |
| Sep 2026 | $285.56M | -27.6% | -14.0% | 10.8% | |
| Jun 2026 | $176.7M | -51.4% | -60.7% | 29.3% | |
| Mar 2026 | $168.83M | -7.0% | -3.2% | 39.5% | |
| Sep 2026 | $75.79M | -53.6% | +18.3% | 7.1% | |
| Mar 2026 | $29.49M | -6.5% | -33.0% | 4.6% | |
| Peer median (excluding MLAB) | $953.54M | -3.7% | -6.8% | 27.8% | |
Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 49.35M | 32.91M | 28.21M | 27.32M | 26.93M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 41.22M | 42.55M | 39.06M | 41.97M | 44.1M |
| Inventory | 24.61M | 34.64M | 32.68M | 25.37M | 26.37M |
| Other Current Assets | 9.14M | 4.05M | 3.34M | 2.87M | 3.62M |
| Total Current Assets | 124.32M | 118.98M | 109.35M | 102.69M | 106.27M |
| Property, Plant & Equipment (Net) | 28.62M | 28.15M | 41.44M | 32.33M | 48.11M |
| Goodwill | 291.17M | 286.44M | 180.1M | 181.76M | 186.86M |
| Intangible Assets | 250.12M | 216.82M | 113.75M | 96.88M | 83.35M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.32M | 1.08M | 1.29M | 1.37M | 1.5M |
| Other Non-current Assets | 11.83M | 10.37M | 867K | 18.32M | 1.66M |
| Total Non-current Assets | 583.05M | 542.86M | 337.44M | 330.66M | 321.48M |
| Total Assets | 707.37M | 661.83M | 446.8M | 433.35M | 427.75M |
| Account Payables | 7.9M | 6.13M | 6.04M | 5.75M | 4.93M |
| Short-term Debt | 0 | 0 | 0 | 101.05M | 5.63M |
| Tax Payables | 7.96M | 8.92M | 1.62M | 10.63M | 0 |
| Deferred Revenue | 14.58M | 15.69M | 15.48M | 14.71M | 14.72M |
| Other Current Liabilities | 0 | 0 | 15.49M | 0 | 11.5M |
| Total Current Liabilities | 48.06M | 43.36M | 44.31M | 163.96M | 61.9M |
| Long-term Debt | 218.37M | 183.27M | 221.7M | 76.9M | 145.86M |
| Deferred Tax Liabilities | 39.22M | 34.03M | 19.78M | 20.18M | 20.09M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 7.92M | 7.69M | 9M | 12.47M | 0 |
| Total Non-current Liabilities | 265.51M | 224.99M | 257.09M | 109.56M | 179.6M |
| Total Liabilities | 313.57M | 268.35M | 301.4M | 273.52M | 241.5M |
| Common Stock | 313.46M | 332.08M | 343.64M | 358.54M | 375.35M |
| Retained Earnings | 76.68M | 74.2M | (183.49M) | (188.94M) | (185.75M) |
| Accumulated OCI | 3.67M | (12.8M) | (14.76M) | (9.78M) | (3.36M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 393.8M | 393.48M | 145.39M | 159.83M | 186.25M |
| Total Debt | 221.13M | 186.14M | 231.3M | 181.47M | 168.83M |
| Net Debt | 171.79M | 153.23M | 203.08M | 154.15M | 141.9M |
Mesa Laboratories, Inc.
NASDAQ:MLAB
Intrinsic Alpha fair value
Locked
Current Price
$137.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.